Cargando…
Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study
BACKGROUND: In studies including the general population, the presence of non-malignant monoclonal gammopathy (MG) can be causally associated with kidney damage and shorter survival. We assessed whether the presence of an MG is associated with a higher risk of kidney failure or death in individuals w...
Autores principales: | Fenton, Anthony, Chinnadurai, Rajkumar, Gullapudi, Latha, Kampanis, Petros, Dasgupta, Indranil, Ritchie, James, Harding, Stephen, Ferro, Charles J., Kalra, Philip A., Taal, Maarten W., Cockwell, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048272/ https://www.ncbi.nlm.nih.gov/pubmed/32109242 http://dx.doi.org/10.1371/journal.pmed.1003050 |
Ejemplares similares
-
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies
por: Tietsche de Moraes Hungria, Vania, et al.
Publicado: (2016) -
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
por: Leung, Nelson, et al.
Publicado: (2018) -
Monoclonal gammopathies
por: Tozzi, S
Publicado: (2010) -
Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group
por: Leung, Nelson, et al.
Publicado: (2018) -
Cardiovascular Associations With Monoclonal Gammopathy of Undetermined Significance: Real or Coincidental?
por: Kapoor, Prashant, et al.
Publicado: (2022)